Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03190993 · ClinicalTrials.gov registry record · NA

The DEB Pilot Study

A NA study of Obesity and Nutritional Physiological Phenomena, sponsored by Pennington Biomedical Research Center.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT03190993 is a NA study of Obesity and Nutritional Physiological Phenomena that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 20 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03190993, a NA study of Obesity and Nutritional Physiological Phenomena, has completed, sponsored by Pennington Biomedical Research Center.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of the current study is to test if weight change is differentially affected by consumption of foods that are identical in carbohydrate (i.e. sugar) but vary in food form over 1 month.

Interventions

  • OTHER Sugar Sweetened Solid Treatment
  • OTHER Sugar Sweetened Beverage Treatment

Study Locations (1)

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2017-07-21
Est. Completion 2018-06-21
Phase NA

What the Registry Record Tells You About NCT03190993

The ClinicalTrials.gov registry entry for NCT03190993 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Sugar Sweetened Solid Treatment is the first listed.

NCT03190993 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT03190993 about?

NCT03190993 is a clinical study titled "The DEB Pilot Study". The purpose of the current study is to test if weight change is differentially affected by consumption of foods that are identical in carbohydrate (i.e. sugar) but vary in food form over 1 month.

What is the current status of trial NCT03190993?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-07-21. Estimated completion is 2018-06-21.

What conditions does trial NCT03190993 study?

This clinical trial studies the following conditions: Obesity, Nutritional Physiological Phenomena.

What interventions are being tested in trial NCT03190993?

The interventions under investigation include: Sugar Sweetened Solid Treatment (OTHER), Sugar Sweetened Beverage Treatment (OTHER).

Who is sponsoring clinical trial NCT03190993?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03190993 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.